CD19-Targeted T Cells for Hematologic Malignancies

Cancer Journal - United States
doi 10.1097/ppo.0000000000000153
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Hematologic Malignancies

Oncologist
Cancer ResearchMedicineOncology
1999English

piggyBacTransposon/Transposase System to Generate CD19-Specific T Cells for the Treatment of B-Lineage Malignancies

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2010English

MDS as a Cause for Prolonged Hematologic Toxicity After Treatment With Cd19 Targeted Car-T Cell Therapy in Patients With Relapsed Refractory Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Dendritic Cell Therapies for Hematologic Malignancies

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2017English

Chylothorax in Hematologic Malignancies

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Combining CD19 Redirection and Alloanergization to Generate Tumor-Specific Human T Cells for Allogeneic Cell Therapy of B-Cell Malignancies

Cancer Research
Cancer ResearchOncology
2010English

Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins

English

Vaccine Therapy in Hematologic Malignancies

Blood
BiochemistryImmunologyCell BiologyHematology
2018English

Targeted T Cells for Anticancer Therapy

Science-Business eXchange
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy